401k Plan data: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU plan

PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 401k Plan overview

Plan Name	PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU
Plan identification number	001

PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

PATHWAY GENOMICS CORPORATION has sponsored the creation of one or more 401k plans.

Company Name: PATHWAY GENOMICS CORPORATION

Employer identification number (EIN): 262897408

NAIC Classification: 541990
NAIC Description: All Other Professional, Scientific, and Technical Services

Additional information about PATHWAY GENOMICS CORPORATION

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 4556391

More information about PATHWAY GENOMICS CORPORATION

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2019-01-01
001 2018-01-01
001 2017-01-01 STEPHANIE COX
001 2017-01-01 STEPHANIE COX
001 2017-01-01
001 2016-01-01 KLENE OEN
001 2016-01-01 KLENE OEN 2017-10-12
001 2015-01-01 2016-10-31
001 2015-01-01 WENDY PEVERI
001 2015-01-01 KLENE OEN KLENE OEN 2016-11-01
001 2015-01-01 WENDY PEVERI
001 2014-01-01 KLENE OEN
001 2013-01-01 JAMES PLANTE 2014-11-03
001 2012-01-01 PATHWAY GENOMICS CORPORATION 2013-06-24
001 2011-01-01 PATHWAY GENOMICS CORPORATION 2012-05-09
001 2010-01-01 PATHWAY GENOMICS CORPORATION 2011-08-26

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2019-01-01
001	2018-01-01
001	2017-01-01	STEPHANIE COX
001	2017-01-01	STEPHANIE COX
001	2017-01-01
001	2016-01-01	KLENE OEN
001	2016-01-01			KLENE OEN	2017-10-12
001	2015-01-01		2016-10-31
001	2015-01-01	WENDY PEVERI
001	2015-01-01	KLENE OEN		KLENE OEN	2016-11-01
001	2015-01-01	WENDY PEVERI
001	2014-01-01	KLENE OEN
001	2013-01-01	JAMES PLANTE	2014-11-03
001	2012-01-01	PATHWAY GENOMICS CORPORATION	2013-06-24
001	2011-01-01	PATHWAY GENOMICS CORPORATION	2012-05-09
001	2010-01-01	PATHWAY GENOMICS CORPORATION	2011-08-26

Plan Statistics for PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU

401k plan membership statisitcs for PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU

Measure Date Value
2019: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2019 401k membership
Total participants, beginning-of-year 2019-01-01 107
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 11
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 54
Total of all active and inactive participants 2019-01-01 65
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 65
Number of participants with account balances 2019-01-01 57
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2018 401k membership
Total participants, beginning-of-year 2018-01-01 115
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 54
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 52
Total of all active and inactive participants 2018-01-01 106
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 106
Number of participants with account balances 2018-01-01 76
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2017 401k membership
Total participants, beginning-of-year 2017-01-01 146
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 62
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 45
Total of all active and inactive participants 2017-01-01 107
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 107
Number of participants with account balances 2017-01-01 67
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2016 401k membership
Total participants, beginning-of-year 2016-01-01 165
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 112
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 35
Total of all active and inactive participants 2016-01-01 147
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 147
Number of participants with account balances 2016-01-01 71
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2015 401k membership
Total participants, beginning-of-year 2015-01-01 143
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 135
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 26
Total of all active and inactive participants 2015-01-01 161
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 161
Number of participants with account balances 2015-01-01 63
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2014 401k membership
Total participants, beginning-of-year 2014-01-01 134
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 158
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 20
Total of all active and inactive participants 2014-01-01 178
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 178
Number of participants with account balances 2014-01-01 54
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0

Measure	Date	Value
2019: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2019 401k membership
Total participants, beginning-of-year	2019-01-01	107
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	11
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	54
Total of all active and inactive participants	2019-01-01	65
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	65
Number of participants with account balances	2019-01-01	57
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2018 401k membership
Total participants, beginning-of-year	2018-01-01	115
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	54
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	52
Total of all active and inactive participants	2018-01-01	106
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	106
Number of participants with account balances	2018-01-01	76
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2017 401k membership
Total participants, beginning-of-year	2017-01-01	146
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	62
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	45
Total of all active and inactive participants	2017-01-01	107
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	107
Number of participants with account balances	2017-01-01	67
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2016 401k membership
Total participants, beginning-of-year	2016-01-01	165
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	112
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	35
Total of all active and inactive participants	2016-01-01	147
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	147
Number of participants with account balances	2016-01-01	71
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2015 401k membership
Total participants, beginning-of-year	2015-01-01	143
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	135
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	26
Total of all active and inactive participants	2015-01-01	161
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	161
Number of participants with account balances	2015-01-01	63
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2014 401k membership
Total participants, beginning-of-year	2014-01-01	134
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	158
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	20
Total of all active and inactive participants	2014-01-01	178
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	178
Number of participants with account balances	2014-01-01	54
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0

Financial Data on PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU

Measure	Date	Value
2019 : PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$436,144
Total income from all sources (including contributions)	2019-12-31	$436,144
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$810,352
Total of all expenses incurred	2019-12-31	$810,352
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$796,023
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$796,023
Expenses. Certain deemed distributions of participant loans	2019-12-31	$128
Expenses. Certain deemed distributions of participant loans	2019-12-31	$128
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$155,530
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$155,530
Value of total assets at end of year	2019-12-31	$1,081,448
Value of total assets at end of year	2019-12-31	$1,081,448
Value of total assets at beginning of year	2019-12-31	$1,455,656
Value of total assets at beginning of year	2019-12-31	$1,455,656
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$14,201
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$14,201
Total interest from all sources	2019-12-31	$128
Total interest from all sources	2019-12-31	$128
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$36,333
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$36,333
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$36,333
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$36,333
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$146,000
Value of fidelity bond cover	2019-12-31	$146,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$155,530
Contributions received from participants	2019-12-31	$155,530
Other income not declared elsewhere	2019-12-31	$1,150
Other income not declared elsewhere	2019-12-31	$1,150
Administrative expenses (other) incurred	2019-12-31	$14,201
Administrative expenses (other) incurred	2019-12-31	$14,201
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$-374,208
Value of net income/loss	2019-12-31	$-374,208
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$1,081,448
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$1,081,448
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$1,455,656
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$1,455,656
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$912,584
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$912,584
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$1,205,356
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$1,205,356
Interest on participant loans	2019-12-31	$128
Interest on participant loans	2019-12-31	$128
Value of interest in common/collective trusts at end of year	2019-12-31	$168,864
Value of interest in common/collective trusts at end of year	2019-12-31	$168,864
Value of interest in common/collective trusts at beginning of year	2019-12-31	$250,300
Value of interest in common/collective trusts at beginning of year	2019-12-31	$250,300
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$238,775
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$238,775
Net investment gain or loss from common/collective trusts	2019-12-31	$4,228
Net investment gain or loss from common/collective trusts	2019-12-31	$4,228
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$796,023
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$796,023
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	AUDIT AND TAX SOLUTIONS CPAS INC
Accountancy firm name	2019-12-31	AUDIT AND TAX SOLUTIONS CPAS INC
Accountancy firm EIN	2019-12-31	943211753
Accountancy firm EIN	2019-12-31	943211753
2018 : PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total transfer of assets from this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$219,202
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$336,481
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$321,921
Expenses. Certain deemed distributions of participant loans	2018-12-31	$122
Value of total corrective distributions	2018-12-31	$4,980
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$278,135
Value of total assets at end of year	2018-12-31	$1,455,656
Value of total assets at beginning of year	2018-12-31	$1,572,935
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$9,458
Total interest from all sources	2018-12-31	$122
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$67,408
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$67,408
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$158,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$278,135
Administrative expenses (other) incurred	2018-12-31	$9,458
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-117,279
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$1,455,656
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$1,572,935
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$1,205,356
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$1,349,694
Interest on participant loans	2018-12-31	$122
Value of interest in common/collective trusts at end of year	2018-12-31	$250,300
Value of interest in common/collective trusts at beginning of year	2018-12-31	$223,241
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-131,121
Net investment gain or loss from common/collective trusts	2018-12-31	$4,658
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$321,921
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	AUDIT AND TAX SOLUTIONS, CPAS, INC.
Accountancy firm EIN	2018-12-31	943211753
2017 : PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$0
Total transfer of assets from this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$530,753
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$446,348
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$435,997
Expenses. Certain deemed distributions of participant loans	2017-12-31	$2,211
Value of total corrective distributions	2017-12-31	$4,353
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$343,152
Value of total assets at end of year	2017-12-31	$1,572,935
Value of total assets at beginning of year	2017-12-31	$1,488,530
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$3,787
Total interest from all sources	2017-12-31	$120
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$44,252
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$44,252
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$149,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$304,502
Participant contributions at beginning of year	2017-12-31	$2,422
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$38,650
Other income not declared elsewhere	2017-12-31	$2,920
Administrative expenses (other) incurred	2017-12-31	$3,787
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$84,405
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$1,572,935
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$1,488,530
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$1,349,694
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$1,192,234
Interest on participant loans	2017-12-31	$120
Value of interest in common/collective trusts at end of year	2017-12-31	$223,241
Value of interest in common/collective trusts at beginning of year	2017-12-31	$293,874
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$136,093
Net investment gain or loss from common/collective trusts	2017-12-31	$4,216
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$435,997
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	SQUARMILNER
Accountancy firm EIN	2017-12-31	330835986
2016 : PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$0
Total transfer of assets from this plan	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$657,751
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$375,911
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$355,545
Value of total corrective distributions	2016-12-31	$12,485
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$548,612
Value of total assets at end of year	2016-12-31	$1,488,530
Value of total assets at beginning of year	2016-12-31	$1,206,690
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$7,881
Total interest from all sources	2016-12-31	$13
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$30,553
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$30,553
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$121,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$394,390
Participant contributions at end of year	2016-12-31	$2,422
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$154,222
Other income not declared elsewhere	2016-12-31	$2,418
Administrative expenses (other) incurred	2016-12-31	$7,881
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$281,840
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$1,488,530
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$1,206,690
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$1,192,234
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$1,047,706
Interest on participant loans	2016-12-31	$13
Value of interest in common/collective trusts at end of year	2016-12-31	$293,874
Value of interest in common/collective trusts at beginning of year	2016-12-31	$158,984
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$76,022
Net investment gain or loss from common/collective trusts	2016-12-31	$133
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$355,545
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	SQUARMILNER
Accountancy firm EIN	2016-12-31	330835986
2015 : PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets from this plan	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$533,484
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$513,945
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$511,740
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$562,694
Value of total assets at end of year	2015-12-31	$1,206,690
Value of total assets at beginning of year	2015-12-31	$1,187,151
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$2,205
Total interest from all sources	2015-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$5,733
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$5,733
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$119,000
If this is an individual account plan, was there a blackout period	2015-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$344,240
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$218,454
Administrative expenses (other) incurred	2015-12-31	$2,205
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$19,539
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$1,206,690
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$1,187,151
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$1,047,706
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$1,066,343
Value of interest in common/collective trusts at end of year	2015-12-31	$158,984
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$120,808
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$120,808
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-35,624
Net investment gain or loss from common/collective trusts	2015-12-31	$681
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$511,740
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-12-31	Yes
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	SQUAR MILNER
Accountancy firm EIN	2015-12-31	330835986
2014 : PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$692,050
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$228,145
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$225,881
Expenses. Certain deemed distributions of participant loans	2014-12-31	$0
Value of total corrective distributions	2014-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$648,631
Value of total assets at end of year	2014-12-31	$1,187,151
Value of total assets at beginning of year	2014-12-31	$723,246
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$2,264
Total interest from all sources	2014-12-31	$19
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$47,340
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$47,340
Was this plan covered by a fidelity bond	2014-12-31	No
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$408,169
Participant contributions at end of year	2014-12-31	$0
Participant contributions at beginning of year	2014-12-31	$0
Participant contributions at end of year	2014-12-31	$0
Participant contributions at beginning of year	2014-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2014-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2014-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$240,462
Value of other receiveables (less allowance for doubtful accounts) at end of year	2014-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2014-12-31	$0
Administrative expenses (other) incurred	2014-12-31	$2,264
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$463,905
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$1,187,151
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$723,246
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$1,066,343
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$619,220
Value of interest in pooled separate accounts at end of year	2014-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$0
Interest on participant loans	2014-12-31	$4
Value of interest in master investment trust accounts at end of year	2014-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2014-12-31	$0
Value of interest in common/collective trusts at end of year	2014-12-31	$0
Value of interest in common/collective trusts at beginning of year	2014-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$120,808
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$104,026
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$104,026
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$15
Assets. Value of investments in 103.12 investment entities at end of year	2014-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2014-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-3,940
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$0
Employer contributions (assets) at end of year	2014-12-31	$0
Employer contributions (assets) at beginning of year	2014-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$225,881
Contract administrator fees	2014-12-31	$0
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	SQUARMILNER

Form 5500 Responses for PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU

2019: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	Yes
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	Yes
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: PATHWAY GENOMICS CORPORATION 401K PROFIT SHARING PLAN AND TRU 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	PATHWAY GENOMICS CORPORATION
Employer identification number (EIN):	262897408
NAIC Classification:	541990
NAIC Description:	All Other Professional, Scientific, and Technical Services

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	4556391